Accuracy of Rating Scales and Clinical Measures for Screening of Rapid eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson's Disease and Other Synucleinopathies
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F18%3A10375718" target="_blank" >RIV/00216208:11110/18:10375718 - isvavai.cz</a>
Alternative codes found
RIV/68407700:21230/18:00321829 RIV/00064165:_____/18:10375718
Result on the web
<a href="https://doi.org/10.3389/fneur.2018.00376" target="_blank" >https://doi.org/10.3389/fneur.2018.00376</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3389/fneur.2018.00376" target="_blank" >10.3389/fneur.2018.00376</a>
Alternative languages
Result language
angličtina
Original language name
Accuracy of Rating Scales and Clinical Measures for Screening of Rapid eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson's Disease and Other Synucleinopathies
Original language description
Rapid eye movement (REM) sleep behavior disorder (RBD) is characterized by repeated episodes of REM sleep-related vocalizations and/or complex motor behaviors. Definite diagnosis of RBD is based on history and polysomnography, both of which are less accessible due to the lack of trained specialists and high cost. While RBD may be associated with disorders like narcolepsy, focal brain lesions, and encephalitis, idiopathic RBD (iRBD) may convert to Parkinson's disease (PD) and other synucleinopathies in more than 80% of patients and it is to date the most specific clinical prodromal marker of PD. Identification of individuals at high risk for development of PD is becoming one of the most important topics for current PD-related research as well as for future treatment trials targeting prodromal PD. Furthermore, concomitant clinical symptoms, such as subtle motor impairment, hyposmia, autonomic dysfunction, or cognitive difficulties, in subjects with iRBD may herald its phenoconversion to clinically manifest parkinsonism. The assessment of these motor and non-motor symptoms in iRBD may increase the sensitivity and specificity in identifying prodromal PD subjects. This review evaluates the diagnostic accuracy of individual rating scales and validated single items for screening of RBD and the role and accuracy of available clinical, electrophysiological, imaging, and tissue biomarkers in predicting the phenoconversion from iRBD to clinically manifest synucleinopathies
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30103 - Neurosciences (including psychophysiology)
Result continuities
Project
<a href="/en/project/NV16-28914A" target="_blank" >NV16-28914A: REM sleep behavior disorder – clinical presentation, disease course and its implications</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Frontiers in Neurology
ISSN
1664-2295
e-ISSN
—
Volume of the periodical
9
Issue of the periodical within the volume
May
Country of publishing house
CH - SWITZERLAND
Number of pages
18
Pages from-to
—
UT code for WoS article
000433149500001
EID of the result in the Scopus database
2-s2.0-85047517557